Long-term efficacy of biologic treatment for psoriasis after COVID-19 infection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long-term efficacy of biologic treatment for psoriasis after COVID-19 infection

Published:2022-11-01 Issue:11 Volume:47 Page:2025-2026
ISSN:1365-2230
Container-title:Clinical and Experimental Dermatology
language:en
Short-container-title:

Author:

Bakirtzi Katerina¹^ORCID,Papadimitriou Ilias¹^ORCID,Vakirlis Efstratios¹,Chatzi-Sotiriou Themis²,Ioannides Dimitrios¹,Sotiriou Eleni¹^ORCID

Affiliation:

1. First Department of Dermatology and Venereology, School of Medicine Aristotle University of Thessaloniki Thessaloniki Greece

2. Department of International and European Studies, School of Social Sciences, Humanities and Arts University of Macedonia Thessaloniki Greece

Publisher

Oxford University Press (OUP)

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ced.15312

Reference4 articles.

1. New generation biologics for the treatment of psoriasis and psoriatic arthritis. State of the art and considerations about the risk of infection;Ceccarelli;Dermatol Ther,2021

2. Risk of COVID-19 infection, hospitalization, and mortality in patients with psoriasis treated by interleukin-17 inhibitors;Kridin;J Dermatolog Treat,2022

3. If skin is a potential host of SARS-CoV-2, IL-17 antibody could reduce the risk of COVID-19;Xu;J Am Acad Dermatol,2021

4. Immunosuppressive drugs for patients with psoriasis during the COVID-19 pandemic era. A review;Sadeghinia;Dermatol Ther,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dermoscopic Prediction of Therapeutic Response in Psoriatic Lesions Treated with Methotrexate and Apremilast: An Observational Study on Skin Color;Journal of Skin and Stem Cell;2023-02-17

2. The impact of COVID-19 infection on patients with psoriasis treated with biologics: an Italian experience;Clinical and Experimental Dermatology;2022-12-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3